The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Interleukin-1 and inflammatory neurodegeneration
Abstract
Inflammation occurs rapidly in response to acute brain insults such as stroke, haemorrhage or trauma, and can be sustained for long periods of time, for example in Alzheimer's or Parkinson's diseases and multiple sclerosis. Experimental evidence indicates that inflammation plays a major role in neurodegeneration under these conditions, and that the cytokine IL-1 (interleukin-1) is a pivotal mediator. IL-1 is expressed rapidly in response to neuronal injury, predominantly by microglia, and elevated levels of endogenous or exogenous IL-1 markedly exacerbate injury. The naturally occurring IL-1RA (IL-1 receptor antagonist) markedly inhibits ischaemic, excitotoxic and traumatic brain injury in rodents, and has shown promise in a Phase II clinical trial in stroke patients. The mechanisms of IL-1 expression, release and action in neurodegeneration are not fully elucidated and appear multiple. Systemic IL-1 markedly enhances ischaemic brain injury via release of neutrophils into circulation, neutrophil adhesion to injured cerebrovasculature and CNS (central nervous system) invasion, and cell death via activation of matrix metalloproteinase-9. IL-1 also influences the release of toxins from glial and endothelial cells. Neuronal responses to excitotoxins and physiological factors may have an impact on neuronal survival. IL-1RA, delivered peripherally, can enter the CNS in animals and humans and has no adverse effects in stroke or subarachnoid haemorrhage patients, but shows potential benefit in acute stroke patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes
Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J., et al. (1992) · Nature · doi:10.1038/356768a0 · Cited by 2,572
The role of inflammation in CNS injury and disease
Lucas, S., Rothwell, N. J., & Gibson, R. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706400 · Cited by 1,272
Self-citationInterleukin-1 and neuronal injury
Allan, S. M., Tyrrell, P. J., & Rothwell, N. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1664 · Cited by 992
Self-citationViviani, B., Bartesaghi, S., Gardoni, F., Vezzani, A., Behrens, M. M., Bartfai, T., Binaglia, M., Corsini, E., Di Luca, M., Galli, C. L., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-25-08692.2003 · Cited by 893
Griffin, W. S. T., Sheng, J. G., Royston, M. C., Gentleman, S. M., McKenzie, J. E., Graham, D. I., Roberts, G. W., & Mrak, R. E. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00136.x · Cited by 708
Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization
Giulian, D., Woodward, J., Young, D., Krebs, J., & Lachman, L. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-07-02485.1988 · Cited by 588
Interleukin-1 as a Pathogenetic Mediator of Ischemic Brain Damage in Rats
Yamasaki, Y., Matsuura, N., Shozuhara, H., Onodera, H., Itoyama, Y., & Kogure, K. (1995) · Stroke · doi:10.1161/01.str.26.4.676 · Cited by 572
O'Neill, L. A. J., & Greene, C. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.63.6.650 · Cited by 561
Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat
Relton, J. K., & Rothwell, N. J. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90033-t · Cited by 546
Self-citationSmith, C. J., Emsley, H. C., Gavin, C. M., Georgiou, R. F., Vail, A., Barberan, E. M., del Zoppo, G. J., Hallenbeck, J. M., Rothwell, N. J., Hopkins, S. J., et al. (2004) · BMC Neurology · doi:10.1186/1471-2377-4-2 · Cited by 480
Self-citationRole of IL-1α and IL-1β in Ischemic Brain Damage
Boutin, H., LeFeuvre, R. A., Horai, R., Asano, M., Iwakura, Y., & Rothwell, N. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05528.2001 · Cited by 477
Self-citationVezzani, A., Moneta, D., Conti, M., Richichi, C., Ravizza, T., De Luigi, A., De Simoni, M. G., Sperk, G., Andell-Jonsson, S., Lundkvist, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190206797 · Cited by 464
Loddick, S. A., & Rothwell, N. J. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00017 · Cited by 463
Self-citationA randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients
Emsley, H. C. A. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054882 · Cited by 445
Fever in Acute Stroke Worsens Prognosis: A Prospective Study
Azzimondi, G., Bassein, L., Nonino, F., Fiorani, L., Vignatelli, L., Re, G., & D’Alessandro, R. (1995) · Stroke · doi:10.1161/01.str.26.11.2040 · Cited by 437
Andrei, C., Margiocco, P., Poggi, A., Lotti, L. V., Torrisi, M. R., & Rubartelli, A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308558101 · Cited by 409
Phenotypic and functional characterization of mice that lack the type I receptor for IL-1
Glaccum, M. B., Stocking, K. L., Charrier, K., Smith, J. L., Willis, C. R., Maliszewski, C., Livingston, D. J., Peschon, J. J., & Morrissey, P. J. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.7.3364 · Cited by 374
McColl, B. W., Rothwell, N. J., & Allan, S. M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5376-06.2007 · Cited by 337
Self-citationInterleukin-1β inhibits long-term potentiation in the CA3 region of mouse hippocampal slices
Katsuki, H., Nakai, S., Hirai, Y., Akaji, K.-I., Kiso, Y., & Satoh, M. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90099-r · Cited by 331
Reduced Ischemic Brain Injury in Interleukin-1β Converting Enzyme—Deficient Mice
Schielke, G. P., Yang, G.-Y., Shivers, B. D., & Betz, A. L. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199802000-00009 · Cited by 302
Betz, A. L., Yang, G.-Y., & Davidson, B. L. (1995) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1995.68 · Cited by 239
Hara, H., Fink, K., Endres, M., Friedlander, R. M., Gagliardini, V., Yuan, J., & Moskowitz, M. A. (1997) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199704000-00002 · Cited by 233
IL‐1‐regulated responses in astrocytes: Relevance to injury and recovery
John, G. R., Lee, S. C., Song, X., Rivieccio, M., & Brosnan, C. F. (2005) · Glia · doi:10.1002/glia.20109 · Cited by 217
Strijbos, P., & Rothwell, N. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03468.1995 · Cited by 214
Self-citationFerrari, C. C., Depino, A. M., Prada, F., Muraro, N., Campbell, S., Podhajcer, O., Perry, V. H., Anthony, D. C., & Pitossi, F. J. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63438-4 · Cited by 207
Kostulas, N., Pelidou, S. H., Kivisäkk, P., Kostulas, V., & Link, H. (1999) · Stroke · doi:10.1161/01.str.30.10.2174 · Cited by 196
Interleukin-1β Induces a Reactive Astroglial Phenotype via Deactivation of the Rho GTPase–Rock Axis
John, G. R., Chen, L., Rivieccio, M. A., Melendez-Vasquez, C. V., Hartley, A., & Brosnan, C. F. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4789-03.2004 · Cited by 172
Lawrence, C. B., Allan, S. M., & Rothwell, N. J. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00136.x · Cited by 171
Self-citation(Peri)vascular production and action of pro-inflammatory cytokines in brain pathology
Konsman, J. P., Drukarch, B., & Van Dam, A.-M. (2007) · Clinical Science · doi:10.1042/cs20060043 · Cited by 167
Tehranian, R., Andell, S., Beni, S. M., Yatsiv, I., Shohami, E., Bartfai, T., Lundkvist, J., & Iverfeldt, K. (2002) · Journal of Neurotrauma · doi:10.1089/089771502320317096 · Cited by 158
Thornton, P., Pinteaux, E., Gibson, R. M., Allan, S. M., & Rothwell, N. J. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03872.x · Cited by 152
Self-citationTouzani, O., Boutin, H., Feuvre, R. A. L., Parker, L. C., Miller, A. J., Luheshi, G. N., & Rothwell, N. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00038.2002 · Cited by 141
Self-citationEndogenous Interleukin-1 Receptor Antagonist is Neuroprotective
Loddick, S. A., Wong, M., Bongiorno, P. B., Gold, P. W., Licinio, J., & Rothwell, N. J. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6436 · Cited by 140
Self-citationRanaivo, H. R., Craft, J. M., Hu, W., Guo, L., Wing, L. K., Eldik, L. J. V., & Watterson, D. M. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4652-05.2006 · Cited by 139
Martin, D., & Near, S. L. (1995) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00108-e · Cited by 133
Brough, D., Feuvre, R. A. L., Iwakura, Y., & Rothwell, N. J. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1054 · Cited by 133
Self-citationLipocortin-1 is an endogenous inhibitor of ischemic damage in the rat brain.
Relton, J. K., Strijbos, P. J. L. M., O’Shaughnessy, C. T., Carey, F., Forder, R. A., Tilders, F. J. H., & Rothwell, N. J. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.174.2.305 · Cited by 133
Self-citationPinteaux, E., Rothwell, N. J., & Boutin, H. (2005) · Glia · doi:10.1002/glia.20308 · Cited by 120
Self-citationDesson, S. E., & Ferguson, A. V. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.041210 · Cited by 103
IL‐1β signalling in glial cells in wildtype and IL‐1RI deficient mice
Parker, L. C., Luheshi, G. N., Rothwell, N. J., & Pinteaux, E. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704715 · Cited by 92
Self-citationBresnihan, B. (2001) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2001.23701 · Cited by 85
Different cytokine levels in thrombolysis patients as predictors for clinical outcome
Mazzotta, G. M., Sarchielli, P., Caso, V., Paciaroni, M., Floridi, A., Floridi, A., & Gallai, V. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00798.x · Cited by 77
Interleukin-1β increases synaptic inhibition in rat hippocampal pyramidal neurons in vitro
Zeise, M. L., Madamba, S. G., & Siggins, G. R. (1992) · Regulatory Peptides · doi:10.1016/0167-0115(92)90002-c · Cited by 74
Gueorguieva, I., Clark, S., McMahon, C. J., Scarth, S., Rothwell, N. J., Tyrrell, P. J., Hopkins, S. J., & Rowland, M. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.03026.x · Cited by 61
Self-citationMechanisms of regulation for interleukin-1β in neurodegenerative disease
Simi, A., Lerouet, D., Pinteaux, E., & Brough, D. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.02.011 · Cited by 58
Self-citationGene regulation by IL‐1β independent of IL‐1R1 in the mouse brain
André, R., Moggs, J. G., Kimber, I., Rothwell, N. J., & Pinteaux, E. (2005) · Glia · doi:10.1002/glia.20302 · Cited by 29
Self-citationGrundy, R. I., Rothwell, N. J., & Allan, S. M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01377-3 · Cited by 16
Self-citation
Cited by
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
The IL-1 family: regulators of immunity
Sims, J. E., & Smith, D. E. (2010) · Nature Reviews Immunology · doi:10.1038/nri2691 · Cited by 1,418
Inflammatory Cytokines in Experimental and Human Stroke
Lambertsen, K. L., Biber, K., & Finsen, B. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.88 · Cited by 732
Microglia: biology and pathology
Graeber, M. B., & Streit, W. J. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0622-0 · Cited by 725
Metadata
- Authors
- Simi, A., Tsakiri, N., Wang, P., & Rothwell, N. J.
- Venue
- Biochemical Society Transactions
- Publisher
- Portland Press Ltd.
- Published
- 2007-10-25
- Volume
- 35
- Issue
- 5
- Pages
- 1122-1126
- ISSN
- 0300-5127 (ISSN-L)
- 1470-8752
- OpenAlex
- W2004973724
- Cited by
- 288
- References
- 47
- FWCI
- 8.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.